Nicola Amodio
- Cancer Research top 0.5%
- MicroRNA in disease regulation 26
- Cancer-related molecular mechanisms research 16
- Hematology top 1%
- Multiple Myeloma Research and Treatments 33
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 18
- Protein Degradation and Inhibitors 14
- Histone Deacetylase Inhibitors Research 10
- PI3K/AKT/mTOR signaling in cancer 7
-
- Cancer Mechanisms and Therapy 11
- Oncology top 5%
- Co-authors
- Pierfrancesco TassonePierosandro TagliaferriMaria Teresa Di MartinoAntonino NeriMarco RossiLavinia RaimondiDaniele CaraccioloAnnamaria Gullà
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Nicola Amodio
79 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 1.8k
- Hematology 941
- Molecular Biology 2.8k
- Pathology and Forensic Medicine 398
- Oncology 538
Countries citing papers authored by Nicola Amodio
This map shows the geographic impact of Nicola Amodio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Amodio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Amodio more than expected).
Fields of papers citing papers by Nicola Amodio
This network shows the impact of papers produced by Nicola Amodio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Amodio. The network helps show where Nicola Amodio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nicola Amodio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2021 | 11 | |
| 6 | 2021 | 29 | |
| 7 | 2021 | 16 | |
| 8 | 2020 | 12 | |
| 9 | 2020 | 25 | |
| 10 | 2020 | 7 | |
| 11 | 2019 | 27 | |
| 12 | 2019 | 35 | |
| 13 | 2018 | 5 | |
| 14 | 2018 | 258 | |
| 15 | 2018 | 15 | |
| 16 | 2017 | 2 | |
| 17 | 2015 | 97 | |
| 18 | 2015 | 93 | |
| 19 | 2014 | 34 | |
| 20 | 2013 | 184 |
About Nicola Amodio
Nicola Amodio is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 83 papers that have together received 3.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (33 papers), MicroRNA in disease regulation (26 papers), RNA Interference and Gene Delivery (18 papers), Cancer-related molecular mechanisms research (16 papers), Protein Degradation and Inhibitors (14 papers), Cancer Mechanisms and Therapy (11 papers), Histone Deacetylase Inhibitors Research (10 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Cancer Research (1.8k citations), Hematology (941 citations) and Molecular Biology (2.8k citations). Nicola Amodio has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Di Martino, Antonino Neri, Marco Rossi, Lavinia Raimondi, Daniele Caracciolo, Annamaria Gullà, Emanuela Leone and Eugenio Morelli. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.